ArticleTherapeutic advances in medical oncology2024

Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma.

Weiwei Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.